 |
eculizumab |
|---|---|
| Trade Name | Soliris |
| Orphan Indication | Myasthenia gravis Myasthenia gravis |
| USA Market Approval | USA |
| USA Designation Date | 2014-06-12 00:00:00 |
| Sponsor | Alexion Pharmaceuticals, Inc.;100 College Steet;New Haven, Connecticut, 06510 |
Learn more about: